Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway. [electronic resource]
Producer: 20160523Description: 19469-82 p. digitalISSN:- 1949-2553
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Antineoplastic Agents, Phytogenic -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Curcumin -- pharmacology
- Dose-Response Relationship, Drug
- Female
- Fibrosarcoma -- blood supply
- Hematopoiesis -- drug effects
- Human Umbilical Vein Endothelial Cells -- drug effects
- Humans
- Mice
- Mice, Inbred C57BL
- Neovascularization, Pathologic
- Signal Transduction -- drug effects
- Swine
- Time Factors
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Vascular Endothelial Growth Factor Receptor-2 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.